The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality: A Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: Colorectal cancer is a major health burden. Screening is recommended in many countries. OBJECTIVE: To estimate the effectiveness of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality in a population-based trial. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of 100,210 individuals aged 50 to 64 years, identified from the population of Oslo city and Telemark County, Norway. Screening was performed in 1999-2000 (55-64-year age group) and in 2001 (50-54-year age group), with follow-up ending December 31, 2011. Of those selected, 1415 were excluded due to prior colorectal cancer, emigration, or death, and 3 could not be traced in the population registry. INTERVENTIONS: Participants randomized to the screening group were invited to undergo screening. Within the screening group, participants were randomized 1:1 to receive once-only flexible sigmoidoscopy or combination of once-only flexible sigmoidoscopy and fecal occult blood testing (FOBT). Participants with positive screening test results (cancer, adenoma, polyp ≥10 mm, or positive FOBT) were offered colonoscopy. The control group received no intervention. MAIN OUTCOMES AND MEASURES: Colorectal cancer incidence and mortality. RESULTS: A total of 98,792 participants were included in the intention-to-screen analyses, of whom 78,220 comprised the control group and 20,572 comprised the screening group (10,283 randomized to receive a flexible sigmoidoscopy and 10,289 to receive flexible sigmoidoscopy and FOBT). Adherence with screening was 63%. After a median of 10.9 years, 71 participants died of colorectal cancer in the screening group vs 330 in the control group (31.4 vs 43.1 deaths per 100,000 person-years; absolute rate difference, 11.7 [95% CI, 3.0-20.4]; hazard ratio [HR], 0.73 [95% CI, 0.56-0.94]). Colorectal cancer was diagnosed in 253 participants in the screening group vs 1086 in the control group (112.6 vs 141.0 cases per 100,000 person-years; absolute rate difference, 28.4 [95% CI, 12.1-44.7]; HR, 0.80 [95% CI, 0.70-0.92]). Colorectal cancer incidence was reduced in both the 50- to 54-year age group (HR, 0.68; 95% CI, 0.49-0.94) and the 55- to 64-year age group (HR, 0.83; 95% CI, 0.71-0.96). There was no difference between the flexible sigmoidoscopy only vs the flexible sigmoidoscopy and FOBT screening groups. CONCLUSIONS AND RELEVANCE: In Norway, once-only flexible sigmoidoscopy screening or flexible sigmoidoscopy and FOBT reduced colorectal cancer incidence and mortality on a population level compared with no screening. Screening was effective both in the 50- to 54-year and the 55- to 64-year age groups. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00119912.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,229
Levin, B., Lieberman, D. A., McFarland, B., Andrews, K. S., Brooks, D., Bond, J., Dash, C., Giardiello, F. M., Glick, S., Johnson, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.002 · Cited by 2,990
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H., Moss, S. M., Amar, S. S., Balfour, T. W., James, P. D., & Mangham, C. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03386-7 · Cited by 2,793
Randomised study of screening for colorectal cancer with faecal-occult-blood test
Kronborg, O., Fenger, C., Olsen, J., Jørgensen, O. D., & Søndergaard, O. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03430-7 · Cited by 2,501
The evolution of cancer of the colon and rectum
Muto, T., Bussey, H. J. R., & Morson, B. C. (1975) · Cancer · doi:10.1002/cncr.2820360944 · Cited by 2,118
Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer
Lieberman, D. A., Weiss, D. G., Bond, J. H., Ahnen, D. J., Garewal, H., Harford, W. V., Provenzale, D., Sontag, S., Schnell, T., Durbin, T. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430301 · Cited by 1,815
Atkin, W. S., Edwards, R., Kralj-Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M., Parkin, D. M., Wardle, J., Duffy, S. W., & Cuzick, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60551-x · Cited by 1,623
Imperiale, T. F., Wagner, D. R., Lin, C. Y., Larkin, G. N., Rogge, J. D., & Ransohoff, D. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430302 · Cited by 1,060
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
Schoen, R. E., Pinsky, P. F., Weissfeld, J. L., Yokochi, L. A., Church, T., Laiyemo, A. O., Bresalier, R., Andriole, G. L., Buys, S. S., Crawford, E. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114635 · Cited by 1,021
Instruments for Causal Inference: An Epidemiologist's Dream?
Hernán, M. A., & Robins, J. M. (2006) · Epidemiology · doi:10.1097/01.ede.0000222409.00878.37 · Cited by 961
Self-citationLarsen, I. K., Småstuen, M., Johannesen, T. B., Langmark, F., Parkin, D. M., Bray, F., & Møller, B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.037 · Cited by 848
Segnan, N., Armaroli, P., Bonelli, L., Risio, M., Sciallero, S., Zappa, M., Andreoni, B., Arrigoni, A., Bisanti, L., Casella, C., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr284 · Cited by 620
Lieberman, D. A., Harford, W. V., Ahnen, D. J., Provenzale, D., Sontag, S. J., Schnell, T. G., Chejfec, G., Campbell, D. R., Durbin, T. E., Bond, J. H., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010328 · Cited by 580
Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia
Schoenfeld, P., Cash, B., Flood, A., Dobhan, R., Eastone, J., Coyle, W., Kikendall, J. W., Kim, H. M., Weiss, D. G., Emory, T., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042990 · Cited by 489
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients
Lash, R. H., Genta, R. M., & Schuler, C. M. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.075507 · Cited by 332
Hoff, G., Grotmol, T., Skovlund, E., Bretthauer, M., & for the Norwegian Colorectal Cancer Prevention Study Group (2009) · BMJ · doi:10.1136/bmj.b1846 · Cited by 311
Self-citationCost-effectiveness of Colorectal Cancer Screening
Lansdorp-Vogelaar, I., Knudsen, A. B., & Brenner, H. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxr004 · Cited by 297
Segnan, N. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.23.1763 · Cited by 232
Colorectal cancer screening in Europe
Zavoral, M., Suchanek, S., Zavada, F., Dusek, L., Muzik, J., Seifert, B., & Fric, P. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5907 · Cited by 202
The Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study
Gondal, G., Grotmol, T., Hofstad, B., Bretthauer, M., Eide, T. J., & Hoff, G. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310003002 · Cited by 182
Self-citationCausal Inference from Longitudinal Studies with Baseline Randomization
Toh, S., & Hernán, M. Á. (2008) · The International Journal of Biostatistics · doi:10.2202/1557-4679.1117 · Cited by 131
Self-citationBretthauer, M., Gondal, G., Larsen, I. K., et al. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520252903125 · Cited by 91
Self-citationColorectal Cancer Deaths as Determined by Expert Committee and from Death Certificate
Ederer, F., Geisser, M. S., Mongin, S. J., Church, T. R., & Mandel, J. S. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00016-5 · Cited by 47
Colorectal cancer screening in Europe: differences in approach; similar barriers to overcome
West, N., Boustière, C., Fischbach, W., Parente, F., & Leicester, R. J. (2009) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0690-6 · Cited by 47
Forsberg, A. M., Kjellström, L., Agréus, L., Andréasson, A., Nyhlin, H., Talley, N. J., & Björck, E. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.647062 · Cited by 44
Cited by
Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32319-0 · Cited by 4,974
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F. A. R., Gillman, M. W., Harper, D. M., Kemper, A. R., et al. (2016) · JAMA · doi:10.1001/jama.2016.5989 · Cited by 2,509
Wolf, A. M. D., Fontham, E. T. H., Church, T. R., Flowers, C. R., Guerra, C. E., LaMonte, S. J., Etzioni, R., McKenna, M. T., Oeffinger, K. C., Shih, Y. T., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21457 · Cited by 1,944
Colorectal cancer screening: a global overview of existing programmes
Schreuders, E. H., Ruco, A., Rabeneck, L., Schoen, R. E., Sung, J. J. Y., Young, G. P., & Kuipers, E. J. (2015) · Gut · doi:10.1136/gutjnl-2014-309086 · Cited by 1,328
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Metadata
- Authors
- Holme, Ø., Løberg, M., Kalager, M., Bretthauer, M., Hernán, M. A., Aas, E., Eide, T. J., Skovlund, E., Schneede, J., Tveit, K. M., & Hoff, G.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-08-13
- Volume
- 312
- Issue
- 6
- Pages
- 606
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2087147904
- Cited by
- 425
- References
- 27
- FWCI
- 21.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.